GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (LTS:0J5Q) » Definitions » DeferredTaxAndRevenue

Hologic (LTS:0J5Q) DeferredTaxAndRevenue : $208 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hologic DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Hologic's current deferred tax and revenue for the quarter that ended in Mar. 2024 was $208 Mil.

Hologic DeferredTaxAndRevenue Historical Data

The historical data trend for Hologic's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic DeferredTaxAndRevenue Chart

Hologic Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.50 186.10 198.00 186.50 199.20

Hologic Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.50 232.90 199.20 190.60 208.00

Hologic DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Hologic's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hologic (LTS:0J5Q) Business Description

Traded in Other Exchanges
Address
250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (LTS:0J5Q) Headlines

No Headlines